SOPH Q2 2024 Earnings — SOPHiA GENETICS S.A. Revenue & Financial Results | Market Cap Arena

SOPHSOPHiA GENETICS S.A.

$308M

Q2 2024 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$16M+5.0% YoY

Gross Profit

$11M68.2% margin

Operating Income

-$15M-94.9% margin

Net Income

-$15M-96.1% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

+0.2%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$12M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$181M

Total Liabilities

$60M

Stockholders' Equity

$121M

Cash & Equivalents

$105M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$15M	+5.0%
Gross Profit	$11M	$10M	+7.3%
Operating Income	-$15M	-$20M	+25.2%
Net Income	-$15M	-$21M	+29.0%